Market Research Report

Women's Oncology Detection Solutions Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-11277
  • CAT ID : 7
  • Pages : 98
  • Date : Jun 2023
 

The global Women's Oncology Detection Solutions market was valued at US$ 341.6 million in 2022 and is projected to reach US$ 680.1 million by 2029, at a CAGR of 10.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tissue Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Women's Oncology Detection Solutions include Roche, Abbott Laboratories, Thermo Fisher Scientific, Inc., QIAGEN N.V., BGI, Bio-Rad Laboratories, Inc., Illumina, Inc., MolecularMD and Invivoscribe, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Women's Oncology Detection Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women's Oncology Detection Solutions. This report contains market size and forecasts of Women's Oncology Detection Solutions in global, including the following market information:
Global Women's Oncology Detection Solutions Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Women's Oncology Detection Solutions companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Women's Oncology Detection Solutions Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Women's Oncology Detection Solutions Market Segment Percentages, by Type, 2022 (%)
Tissue Test
Blood Test
Others
Global Women's Oncology Detection Solutions Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Women's Oncology Detection Solutions Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-party Medical Examination Institution
Others
Global Women's Oncology Detection Solutions Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Women's Oncology Detection Solutions Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Women's Oncology Detection Solutions revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Women's Oncology Detection Solutions revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott Laboratories
Thermo Fisher Scientific, Inc.
QIAGEN N.V.
BGI
Bio-Rad Laboratories, Inc.
Illumina, Inc.
MolecularMD
Invivoscribe, Inc.
BioAssay Systems
Labcompare
Outline of Major Chapters:
Chapter 1: Introduces the definition of Women's Oncology Detection Solutions, market overview.
Chapter 2: Global Women's Oncology Detection Solutions market size in revenue.
Chapter 3: Detailed analysis of Women's Oncology Detection Solutions company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Women's Oncology Detection Solutions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Women's Oncology Detection Solutions Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Women's Oncology Detection Solutions Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Women's Oncology Detection Solutions Overall Market Size
2.1 Global Women's Oncology Detection Solutions Market Size: 2022 VS 2029
2.2 Global Women's Oncology Detection Solutions Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Women's Oncology Detection Solutions Players in Global Market
3.2 Top Global Women's Oncology Detection Solutions Companies Ranked by Revenue
3.3 Global Women's Oncology Detection Solutions Revenue by Companies
3.4 Top 3 and Top 5 Women's Oncology Detection Solutions Companies in Global Market, by Revenue in 2022
3.5 Global Companies Women's Oncology Detection Solutions Product Type
3.6 Tier 1, Tier 2 and Tier 3 Women's Oncology Detection Solutions Players in Global Market
3.6.1 List of Global Tier 1 Women's Oncology Detection Solutions Companies
3.6.2 List of Global Tier 2 and Tier 3 Women's Oncology Detection Solutions Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Women's Oncology Detection Solutions Market Size Markets, 2022 & 2029
4.1.2 Tissue Test
4.1.3 Blood Test
4.1.4 Others
4.2 By Type - Global Women's Oncology Detection Solutions Revenue & Forecasts
4.2.1 By Type - Global Women's Oncology Detection Solutions Revenue, 2018-2023
4.2.2 By Type - Global Women's Oncology Detection Solutions Revenue, 2024-2029
4.2.3 By Type - Global Women's Oncology Detection Solutions Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Women's Oncology Detection Solutions Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-party Medical Examination Institution
5.1.4 Others
5.2 By Application - Global Women's Oncology Detection Solutions Revenue & Forecasts
5.2.1 By Application - Global Women's Oncology Detection Solutions Revenue, 2018-2023
5.2.2 By Application - Global Women's Oncology Detection Solutions Revenue, 2024-2029
5.2.3 By Application - Global Women's Oncology Detection Solutions Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Women's Oncology Detection Solutions Market Size, 2022 & 2029
6.2 By Region - Global Women's Oncology Detection Solutions Revenue & Forecasts
6.2.1 By Region - Global Women's Oncology Detection Solutions Revenue, 2018-2023
6.2.2 By Region - Global Women's Oncology Detection Solutions Revenue, 2024-2029
6.2.3 By Region - Global Women's Oncology Detection Solutions Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Women's Oncology Detection Solutions Revenue, 2018-2029
6.3.2 US Women's Oncology Detection Solutions Market Size, 2018-2029
6.3.3 Canada Women's Oncology Detection Solutions Market Size, 2018-2029
6.3.4 Mexico Women's Oncology Detection Solutions Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Women's Oncology Detection Solutions Revenue, 2018-2029
6.4.2 Germany Women's Oncology Detection Solutions Market Size, 2018-2029
6.4.3 France Women's Oncology Detection Solutions Market Size, 2018-2029
6.4.4 U.K. Women's Oncology Detection Solutions Market Size, 2018-2029
6.4.5 Italy Women's Oncology Detection Solutions Market Size, 2018-2029
6.4.6 Russia Women's Oncology Detection Solutions Market Size, 2018-2029
6.4.7 Nordic Countries Women's Oncology Detection Solutions Market Size, 2018-2029
6.4.8 Benelux Women's Oncology Detection Solutions Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Women's Oncology Detection Solutions Revenue, 2018-2029
6.5.2 China Women's Oncology Detection Solutions Market Size, 2018-2029
6.5.3 Japan Women's Oncology Detection Solutions Market Size, 2018-2029
6.5.4 South Korea Women's Oncology Detection Solutions Market Size, 2018-2029
6.5.5 Southeast Asia Women's Oncology Detection Solutions Market Size, 2018-2029
6.5.6 India Women's Oncology Detection Solutions Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Women's Oncology Detection Solutions Revenue, 2018-2029
6.6.2 Brazil Women's Oncology Detection Solutions Market Size, 2018-2029
6.6.3 Argentina Women's Oncology Detection Solutions Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Women's Oncology Detection Solutions Revenue, 2018-2029
6.7.2 Turkey Women's Oncology Detection Solutions Market Size, 2018-2029
6.7.3 Israel Women's Oncology Detection Solutions Market Size, 2018-2029
6.7.4 Saudi Arabia Women's Oncology Detection Solutions Market Size, 2018-2029
6.7.5 UAE Women's Oncology Detection Solutions Market Size, 2018-2029
7 Women's Oncology Detection Solutions Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Women's Oncology Detection Solutions Major Product Offerings
7.1.4 Roche Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Women's Oncology Detection Solutions Major Product Offerings
7.2.4 Abbott Laboratories Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Thermo Fisher Scientific, Inc. Company Summary
7.3.2 Thermo Fisher Scientific, Inc. Business Overview
7.3.3 Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Major Product Offerings
7.3.4 Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.4 QIAGEN N.V.
7.4.1 QIAGEN N.V. Company Summary
7.4.2 QIAGEN N.V. Business Overview
7.4.3 QIAGEN N.V. Women's Oncology Detection Solutions Major Product Offerings
7.4.4 QIAGEN N.V. Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.4.5 QIAGEN N.V. Key News & Latest Developments
7.5 BGI
7.5.1 BGI Company Summary
7.5.2 BGI Business Overview
7.5.3 BGI Women's Oncology Detection Solutions Major Product Offerings
7.5.4 BGI Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.5.5 BGI Key News & Latest Developments
7.6 Bio-Rad Laboratories, Inc.
7.6.1 Bio-Rad Laboratories, Inc. Company Summary
7.6.2 Bio-Rad Laboratories, Inc. Business Overview
7.6.3 Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Major Product Offerings
7.6.4 Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.6.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.7 Illumina, Inc.
7.7.1 Illumina, Inc. Company Summary
7.7.2 Illumina, Inc. Business Overview
7.7.3 Illumina, Inc. Women's Oncology Detection Solutions Major Product Offerings
7.7.4 Illumina, Inc. Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.7.5 Illumina, Inc. Key News & Latest Developments
7.8 MolecularMD
7.8.1 MolecularMD Company Summary
7.8.2 MolecularMD Business Overview
7.8.3 MolecularMD Women's Oncology Detection Solutions Major Product Offerings
7.8.4 MolecularMD Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.8.5 MolecularMD Key News & Latest Developments
7.9 Invivoscribe, Inc.
7.9.1 Invivoscribe, Inc. Company Summary
7.9.2 Invivoscribe, Inc. Business Overview
7.9.3 Invivoscribe, Inc. Women's Oncology Detection Solutions Major Product Offerings
7.9.4 Invivoscribe, Inc. Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.9.5 Invivoscribe, Inc. Key News & Latest Developments
7.10 BioAssay Systems
7.10.1 BioAssay Systems Company Summary
7.10.2 BioAssay Systems Business Overview
7.10.3 BioAssay Systems Women's Oncology Detection Solutions Major Product Offerings
7.10.4 BioAssay Systems Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.10.5 BioAssay Systems Key News & Latest Developments
7.11 Labcompare
7.11.1 Labcompare Company Summary
7.11.2 Labcompare Business Overview
7.11.3 Labcompare Women's Oncology Detection Solutions Major Product Offerings
7.11.4 Labcompare Women's Oncology Detection Solutions Revenue in Global Market (2018-2023)
7.11.5 Labcompare Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe